Clinical Trial Update: Hypoxia-inducible Factor-1 (HIF-1) Regulated Circulating Angiogenic Cells (CACs) Recruitment in Burn Wound Healing [NA]

View source ↗

Summary

A terminated clinical trial from Johns Hopkins on HIF-1 regulated circulating angiogenic cells in burn wound healing; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns
• Wound Healing

Snippet

Sponsor: Johns Hopkins University | Conditions: Wound Healing, Burns | NA | Status: TERMINATED | Results posted: 2017-09-29